Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Q1 2026 showed $27M GAAP net income, $749M revenue, and $40M adjusted EBITDA, with membership up 51% YoY. Positive Medicare Advantage sentiment from the CMS 2027 rate increase and a roughly 46% 21-day rally support near-term upside.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Profit rebound ⢠Strong cash flow ⢠Thin equity base CLOV's latest quarter showed a clear turnaround with strong revenue, positive operating and net income, and robust free cash flow, but the investment case is still tempered by last year's losses and a thin equity cushion.
Price Behavior
Key Price Behavior Insights: ⢠Support rebound ⢠Overhead resistance ⢠Choppy base Support Level: $4.10-$4.20 Resistance Level: $4.60-$4.80 CLOV has rebounded from support around $4.10-$4.20 after a sharp drop, but it remains range-bound below $4.60-$4.80 resistance and has not yet confirmed a durable reversal.
Sentiment & News
Key News Insights: ⢠Membership Growth ⢠Raised Guidance ⢠Cyber Incident Clover Health showed clear operational momentum in Q2 with membership growth, GAAP profit, and raised guidance, while a minor cyber incident and CEO share sale remained secondary headlines.
AI Summary
CLOV now looks less like a pure story stock and more like an early operating turnaround, with GAAP profitability, strong free cash flow, and raised guidance signaling real earnings powerâbut the key test is whether membership growth and medical-cost control can sustain these margins over multiple quarters, or the re-rating will stall; watch the 4.10â4.20 support zone and next earnings for confirmation.
Description
Clover Health Investments, Corp. is a U.S. insurer that offers Medicare Advantage products to eligible beneficiaries, delivering plan administration through its Clover Assistant software platform and operating both PPO and HMO plan types. The company also conducts non-insurance activities alongside its core insurance business. Founded in 2014, Clover Health is headquartered in Franklin, Tennessee.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| May 7 | May 14 | CLOV | Clover Health Investments, Corp. | Q1 2026 showed $27M GAAP net income, $749M revenue, and $40M adjusted EBITDA, with membership up 51% YoY. Positive Medicare Advantage sentiment from the CMS 2027 rate increase and a roughly 46% 21-day rally support near-term upside. | Closed | +23.8% |